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ABSTRACT  
 
Introduction 
There are few recent longitudinal studies on smokeless tobacco products (SLT) and smoking outside 
the United States or European Nordic countries. The present longitudinal study tests whether Swedish 
type snus and nasal snuff use decreases smoking incidence and prevalence in a central European 
country.  
Methods  
The sample consisted of 5,198 Swiss men (around 20 years of age).  Retention rate was 91.5% over 
15 months. Regression models, adjusting for a variety of psychosocial, smoking-related, and other risk 
factors, assessed whether no, low (<weekly) and high (weekly+) use baseline groups showed 
changes or maintenance in snus and snuff use related to smoking initiation, cessation, and reduction.  
Results 
Among baseline non-smokers, snus initiators (OR=1.90, p=.003) and low baseline maintainers 
(OR=4.51, p<.001) were more likely to start smoking (reference: persistent non-users of snus).  
Among baseline smokers, initiators (OR=2.79, p<.001) and low baseline maintainers (OR=2.71, 
p=.005) more often continued smoking, whereas snus quitters less frequently continued smoking 
(OR=0.57, p=.009). High baseline maintainers were non-significantly less likely to continue smoking 
(OR=0.71, p=.315). Among continuing smokers, only snus quitters significantly reduced the number of 
cigarettes smoked per day (b=-1.61, p=.002) compared to persistent non-users of snus. Results were 
similar for snuff.  
Conclusions 
SLT use did not have any significant beneficial effects on young men in Switzerland, but significantly 
increased the likelihood of smoking initiation and continuation, independent of whether the substance 
is legally sold (snuff) or not (snus). This does not exclude that there may be beneficial effects at older 
ages.    
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IMPLICATIONS 
Our research provides evidence that SLT use has no benefits for cigarette smoking initiation, 
cessation or reduction among young men in a central European country, where SLT is not highly 
promoted or receives tax incentives. This is true for both legally sold nasal snuff and Swedish type 
snus that cannot be legally sold. Results indicate that without incentives for using it, among young 
people shifts from smoking to SLT use are questionable, and confirms the need for country-specific 
studies before the global public health community engages in promoting smokeless tobacco. 
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INTRODUCTION  
Due to the increased pressure by public health authorities to reduce smoking, the tobacco 
industry has promoted numerous products that seem to be less harmful, such as “light” cigarettes.1  
More recently, electronic cigarettes (e-cigarettes) were patented as a cigarette substitute to help 
smokers quit,2 and quickly became popular.2,3  This has created a heated debate on the pros and cons 
of e-cigarette use.4-6  Other smokeless tobacco (SLT) products, such as dipping tobacco (moist snuff), 
Swedish snus or nasal snuff have currently received less attention.  Recent reviews claimed that the 
existing literature is outdated and focused on the United States and Nordic countries in Europe.7,8  
Therefore, the evidence whether SLT use encourages cessation or reduced smoking is not 
compelling.9  The present study looks at the association between cigarette smoking and SLT (Swedish 
type snus and nasal snuff) use among young men in Switzerland.  E-cigarettes have been analysed 
separately in another study using the same cohort.10 
Smokeless tobacco products, although not free of health risks, do not carry the same risks as 
combustible, smoked tobaccos and may be a less harmful alternative.9,11,12  The increase in snus use, 
predominantly in Nordic countries such as Sweden or Norway, is purported to have contributed to 
lower smoking rates and reduced tobacco-related mortality.13-15  Critics have countered that decreases 
in smoking are mainly related to tobacco control initiatives and probably not due to snus use, since 
age groups having the highest increases in snus use have the lowest quitting rates among smokers.16  
The observation in Scandinavia could not be confirmed in the United States; one of a few non-Nordic 
countries with long availability of SLT.17 The authors therefore recommended that country-specific 
studies are needed before the global public health community engages in promoting smokeless 
tobacco as a way to increase smoking cessation rates.  
One of the crucial questions is whether SLT is a gateway to smoking or a help away from 
smoking,18 particularly among young people.1  However, the gateway effect may apply only to a small 
minority, since most SLT users either never began smoking, or began prior to using SLT.19  It is 
important to distinguish between studies on young people and general population surveys of all ages.  
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Older people might start using tobacco by smoking, then attempt to quit by using SLT, whereas 
younger people might start with SLT, then experiment with conventional cigarettes, leading to dual use 
or cigarettes only.20  The potential for SLT to act as an aid for smoking cessation in older populations, 
after years of heavy smoking and higher levels of nicotine dependence, might not have an equivalent 
mechanism in younger people.21  
Furthermore, SLT use as an aid to smoking cessation is debated. Popova and Ling22 found 
numerous attempts to quit among SLT users, with little indication of successful cessation. 
Randomized trials on SLT use for smoking cessation found few long-term benefits.23,24  SLT is 
sometimes used in addition to cigarettes to provide nicotine in situations where smoking is forbidden, 
such as in public places.20  SLT use may actually reinforce smoking, and the dual use may make it 
even more difficult to quit.25 
 
Snus use in Nordic countries 
Most studies on adolescents and young adults stem from Nordic countries. In Norway, a three-
year-follow up study among more than 1,000 16-year-old males showed increased odds of becoming 
dual users among baseline snus only users compared with no tobacco users or non-smokers.15  Dual 
users were more likely to become smokers only than were snus only users. The authors concluded 
that snus use may facilitate smoking.   
Galanti et al.26 analysed nearly 3,000 11-year-old children in Sweden with 4 annual follow-ups.  
Despite the great availability of snus in Sweden, 69.5% of tobacco users started by smoking 
cigarettes, 11.2% by using snus, and 19.3% by using snus and cigarettes during the same year. 
Cigarette starters were not significantly more likely than snus starters to be smokers by the end of 
follow-up, but mixed starters were more likely to be smokers than the other two starter groups. This 
indicated that starting with snus does not prevent later smoking compared to starting with cigarettes, 
and even increased smoking in follow-up among dual users.  
6 
 
Finland, like Switzerland, has a sales ban on oral snuff like snus, but has easy access to snus 
via Sweden or Norway. Here, 7th graders were followed for 3 years.27  Experimentation with oral moist 
snuff predicted later weekly smoking. Despite the fact that many snus users were active in sports and 
presumed to be less likely to smoke for health reasons, fewer than 10% of snus users had never 
smoked cigarettes by the end of follow-up.  
 
SLT use in the US 
Studies in Nordic countries may not be comparable to situations in other countries, because of 
unique historical and cultural factors associated with SLT use.17  For example, snus use has a long 
history of over a century in Sweden,28 and prices were commonly lower due to lower taxes for snus 
than for cigarettes.17  
Tomar found that males aged 12-18 who were not smokers at baseline but regularly used SLT 
products had a more than three-fold increase in smoking 4 years later, compared with never-users of 
such products.29  O’Connor et al.30 re-analysed the same dataset taking into account a number of well-
known psychosocial factors shown to be related to smoking onset or initiation. The Odds Ratios (OR) 
of Tomar29 for regular SLT use were halved and became non-significant after adjustment.  Similarly, 
Timberlake et al.31 showed that among middle and high school students, a crude significant increase 
in smoking among SLT users became non-significant after propensity matching on a number of 
demographics, smoking-related exposures (e.g. smoking parents), and other risky behaviours 
(cannabis use, binge drinking or not using seat belts). Thus, third variables may be responsible for 
both the uptake of smoking and SLT use. However, even after adjusting for similar confounders other 
authors found that adolescent and young adult SLT users were more likely to initiate smoking than 
were non-SLT users.32,33  Nevertheless, Rodu et al.,34 have shown that once nicotine use starts, SLT 
initiators may be less likely than cigarettes only or dual (in the same year) initiators to become current 
smokers. The study did not compare non-smoking SLT users to non-smoking, non-SLT users, hence 
did not directly answer the question whether SLT use versus no use is a risk factor for future smoking.  
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Hypotheses for Swedish snus and nasal snuff use in Switzerland 
The present research compares the use of nasal snuff which can be legally bought in shops in 
Switzerland and is the most widely used SLT product with a 12-month prevalence of 24% among 
young men in Switzerland35 together with Swedish type snus (9%), which cannot be sold in Swiss 
shops but can be legally imported on an individual basis.36  
Since there is little evidence outside the United States or the European Nordic countries, the 
following two-tailed hypotheses were tested in Switzerland.  
 
1) Among baseline non-smokers, SLT use (snus and snuff) is differentially associated with 
smoking initiation compared to non-use of SLT.   
2) Among baseline smokers, SLT use is differentially associated with smoking cessation 
compared to non-use of SLT.  
3) Among baseline smokers who continue to smoke at follow-up, SLT use is differentially 
associated with smoking reduction compared to non-use of SLT.  
 
METHODS  
Study design and participants 
Data of the present study come from the Cohort Study on Substance Use Risk Factors (C-
SURF) of participants enrolled in army recruitment centres during one year.  Determination of eligibility 
for military or civil service is mandatory for young males. Virtually all males at age 20 must report to 
army recruitment centres, except those who are severely mentally or physically disabled. Enrolment 
was in three of six army centres, encompassing 21 of the 26 Swiss cantons. Although enrolment 
began in the centres, the research was entirely independent of the army. Questionnaires in French or 
German according to the respondents’ language were sent to the home addresses of recruits via 
email with an individual link to an online questionnaire, though participants could request a paper and 
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pencil version.  The research protocol (15/07) has been approved by the ethics committee for clinical 
research of Lausanne University Medical School.  
A total of 7,556 participants gave their written consent, and 5,987 (79.2%) of these completed 
a baseline questionnaire between September 2010 and March 2012. A follow-up questionnaire was 
completed by 5,479 (91.5%) baseline responders between March 2012 and January 2014. The length 
of the follow-up was 15 months on average, but could slightly vary depending on the number of 
reminders needed to receive the completed questionnaires. After listwise deletion of missing values, 
the final analytical sample consisted of 5,198 respondents.  
Details of the enrolment procedure and nonparticipation rates have been presented in a 
previous study.37  Briefly, differences between respondents, non-respondents and non-consenters 
were commonly small and were in different directions. For example, respondents were more often 
alcohol users (93.7%) compared with the total population (92.6%). However, respondents were less 
likely to smoke (37.8%) and to use cannabis (32.5%) compared to the total population (46.2% vs 
34.3%), respectively. 
 
Main independent and dependent measures 
Snus and nasal snuff use frequency was assessed in the past 12 months with a 7-point 
response format ranging from never to daily, coded into frequent (weekly or more often), infrequent 
(less often than weekly) and no use in the past 12 months. Pictures of SLT were provided to help 
respondents distinguish between Swedish type snus (pouches) and nasal snuff. A longitudinal use 
pattern variable for snus and snuff was constructed, indicating whether non-users, infrequent, or 
frequent users at baseline continued using at follow-up. Because only 6.7% (n=8) of frequent snus 
users and 12.2% (n=24) of frequent snuff users at baseline stopped use at follow-up, we combined 
frequent and infrequent baseline users of snus and frequent and infrequent baseline users of snuff 
when they stopped use at follow-up. Also rare were baseline infrequent users who became frequent 
users, since most of them either continued infrequent use or stopped completely. Therefore we 
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combined separately for snus and snuff infrequent and frequent users at follow-up. Thus, the following 
groups were created: 1) no use at both baseline and follow-up (persistent non-users), 2) no use at 
baseline, but use at follow-up (initiators), 3) frequent/infrequent use at baseline but no use at follow-up 
(quitters), 4) infrequent use at baseline and continued use at follow-up (low baseline maintainers) and 
5) frequent use at baseline and continued use at follow-up (high baseline maintainers).  
For smoking, participants were asked at baseline and follow-up whether they had smoked 
cigarettes in the previous twelve months, and how often and how many on typical smoking days. They 
were grouped as non-smokers, occasional (less than daily) smokers, and daily smokers. The number 
of cigarettes smoked per day was also recorded.  
 
Adjustment variables  
As the smoking-SLT-use link may be confounded by other substance use (binge drinking, 
cannabis), risky or deviant behaviours (e.g. physical fights, non-use of seatbelts), smoking norms, or 
predisposing factors (e.g., depressive symptoms, impulsivity), we attempted to adjust for as many 
baseline variables as have been used in prior literature30-33.  
Frequency of three delinquent behaviours (conflicts with police/authorities, arguments or 
fights, and causing property damage) was assessed in the past 12 months, ranging from never, 1-2 
times to 10 times or more. Items originally stem from USA college surveys making explicit mention of 
alcohol attribution,38 but herein were asked without reference to substance use in order to avoid 
predictor-criterion contamination.39  
Frequency of baseline cannabis use in the past 12 months was re-coded into three categories 
(at least weekly, less than weekly, and no use) to provide a measure of risky use. Frequency of binge 
drinking in the past 12 months, i.e. drinking 6 or more standard drinks on an occasion (comparable to 
the 5+ measure with 12 grams per standard drink) was dichotomized into binge drinking at least 
monthly and less than monthly or never.  
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Aggressive personality trait was assessed with the 10-item scale in the short form of the 
Zuckerman-Kuhlman Personality Questionnaire (ZKPQ-50-cc).40  Participants indicated the 
endorsement of 10 dichotomous statements (e.g., When I get mad, I say ugly things; I can't help being 
a little rude to people I do not like), resulting in a score ranging from 0-10.    
Depressive symptomatology was assessed with the Major Depressive Inventory (MDI), a 
screening instrument with 10-items on a 6-point scale, ranging from never to all the time.41 The MDI 
was used to measure depressive symptomatology and not as a dichotomous diagnostic tool, thus a 
total score for the severity of symptoms from 0 (no depression) to 50 (extreme depression) was 
computed.41 
Sensation seeking was measured using the 8-item Brief Sensation Seeking Scale (BSSS).42 
A mean score across all items ranging from 1 (strongly disagree) to 5 (strongly agree) was computed.  
Norm perception of smoking by others was measured with the question “What do you think, 
what percent of young men your age smoke cigarettes?” ranging from 0 to 100. An association with 
own smoking has been shown within the C-SURF sample.43  
As stated in e-cigarettes research,5 nicotine dependence may have a particular impact on the 
effectiveness as an aid for smoking cessation. This was adjusted, using the continuous score of the 
Fagerström Test for Nicotine Dependence,44 ranging from ‘no symptoms of dependence’ (0) to ‘high 
number of symptoms of dependence’ (10).  
Finally, it was adjusted for the sociodemographic variables age, linguistic region (French vs. 
German-speaking), and the perceived financial situation of parents compared with the average in 
Switzerland (below average income, average income and above average income) at baseline.  
 
Statistical analysis 
Chi-squared tests for nominal variables and analysis of variance for continuous variables were 
used to assess baseline differences between non-users, infrequent (less than weekly) and frequent 
(weekly or more often) users of snus and snuff. Changes in prevalence rates of smoking status (non-
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smokers, occasional smokers and daily smokers) were descriptively and unadjusted related to 
changes in snus and snuff use, and then tested in logistic regression models (unadjusted and 
adjusted).  Initiation of smoking was tested for baseline non-smokers, and smoking continuation 
(versus cessation) was tested for baseline smokers. Additionally, among consistent smokers at both 
waves, changes in the number of cigarettes smoked from baseline to follow-up were estimated with 
ordinary least squares (OLS) regression. The difference measure was distributed sufficiently normal 
and allowed an easy interpretation of changes in number of cigarettes smoked per day.  
 
RESULTS 
Baseline users of snus (9.1% of the sample) or snuff (23.5% of the sample) differ from non-
users (see supplementary table S1) in several significant ways.  For example, they were more likely to 
binge drink or use cannabis, had higher sensation seeking and aggressive personality scores, and 
less depressive symptomatology (among snuff users). They were also more likely to engage in deviant 
behaviours, such as property damage, arguments or fights, or problems with the police. Users of snus 
and snuff also had higher nicotine dependence scores.  
Table 1 describes unadjusted changes in cigarette smoking status from baseline to follow-up 
for persistent non-users (snus and snuff), quitters, initiators, and low and high maintainers of SLT use. 
Of the daily smokers at baseline, 6.7% became non-smokers at follow-up if they persistently did not 
use snuff, and 2.5% of daily smokers at baseline became non-smokers if they initiated snuff use.  
Tables 2-4 display the results of the appropriate statistical tests (see supplementary tables S2-4 for 
the same models showing adjustment variables). 
In adjusted models of smoking initiation by baseline non-smokers (Table 2), snus and snuff 
quitters did not differ in smoking initiation rates from persistent non-users. Those initiating snus (OR 
=1.90, p=.003) or snuff use (OR=3.09, p<.001) or maintaining snus or snuff use with low use at 
baseline (OR=4.51, p<.001 for snus, OR =2.18, p<.001 for snuff), were significantly more likely to 
initiate smoking by follow-up. High baseline SLT maintainers did not differ significantly from persistent 
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non-users in initiating smoking, but showed, in the case of snus, non-significantly reduced risk of 
smoking initiation (OR=0.68, p=.418). Adjusting for potential confounders mitigated the effects of the 
unadjusted analyses somewhat, but commonly did not change any levels of significance, except for 
high baseline snuff use maintainers, whose initiation rates of smoking became non-significant 
(OR=1.85, p=.070).  
Baseline smokers who stopped SLT use during follow-up (Table 3) were less likely to continue 
smoking compared to persistent non-users of SLT (OR =0.57, p=.009 for snus; OR =0.66, p=.016 for 
snuff). Initiators of snus (OR=2.79, p<.001) or snuff (OR=1.88, p=.004) were more likely to continue 
smoking than were persistent non-users, as were low baseline maintainers (OR=2.71, p=.005 for 
snus; OR=1.48, p=.031 for snuff).  High baseline maintainers did not differ significantly from persistent 
non-users of SLT, but showed, in the case of snus, non-significantly reduced risk for continued 
smoking (OR=0.71, p=.315). Significance levels did not change when models were adjusted; an 
exception being low baseline snuff maintainers, who were more likely to continue smoking in the 
adjusted model.  
Table 4 shows that, when compared to persistent non-users of SLT, consistent smokers 
differed in number of cigarettes smoked only among SLT quitters.  Snus quitters smoked about 1.6 
cigarettes per day fewer than did persistent non-users (b = -1.61, p=.002); unadjusted changes were 
+.81 cigarettes for persistent non-users and -.83 cigarettes for quitters. Snuff quitters reduced smoking 
by about 1 cigarette per day fewer than persistent non-users (b = -.99, p = .008; unadjusted changes 
were +.66 for persistent non-users and -.27 for quitters).  
 
DISCUSSION  
To our knowledge, the present research is one of the few longitudinal studies on SLT use in 
Europe outside the Nordic countries.7,9 Following our hypotheses, we found that:  
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1) Among baseline non-smokers, SLT initiators and low baseline maintainers were more likely to 
start smoking. SLT quitters and high baseline maintainers did not differ on smoking initiation, 
compared to persistent non-users of SLT.  
2) Among baseline smokers, SLT initiators and low baseline maintainers more often continued 
smoking.  In comparison, SLT quitters less often maintained their smoking habit. High baseline 
maintainers did not differ on smoking continuation, compared to persistent non-users of SLT. 
3) Among consistent smokers, only those stopping SLT use significantly reduced the number of 
cigarettes smoked per day between baseline and follow-up.  
Overall, our findings indicated there were no significant beneficial effects from use of SLT on 
smoking initiation, cessation or reduction for those either initiating or maintaining SLT use. There were 
significant detrimental effects among SLT initiators and low baseline maintainers on smoking initiation 
and cessation. However, for those stopping SLT use, the effects on smoking cessation and reduction 
attempts were beneficial. These findings are consistent with numerous studies among young people in 
Nordic countries 15,26,27 and in the USA.29,32,33  It has been argued that a lack of beneficial effects may 
be due to differences between SLT users and non-users in psychosocial factors, smoking related 
exposures, and other risk taking behaviours.30,31  Nonetheless, even after extensive statistical 
adjustments for these factors, the findings were only partly mitigated (but essentially unchanged), 
despite significant differences in confounding variables between SLT users and non-users. This 
strengthens our findings that the increased odds of smoking initiation and the decreased odds of 
smoking cessation are mainly due to SLT use and not confounding. 
There were differences between persistent non-users and SLT maintainers, depending on 
whether their use was infrequent (less often than weekly) or frequent (weekly or more often). Low 
baseline maintainers were different from persistent non-users as regards smoking outcomes, but not 
high baseline maintainers.  This may indicate that there are two distinct types of “dual users”. There 
may be one group of infrequent users who complement smoking in situations where cigarettes are not 
allowed.20  This dual use may actually make it more difficult to quit smoking.22,25  There may also be 
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another group who actually attempt to cut down or quit smoking by using SLT frequently. High 
baseline maintainers for snus showed non-significantly reduced risks for smoking reduction and 
cessation, whereby non-significance may be due to the low prevalence of snus users in Switzerland 
and may have reached significance in countries with higher use prevalence rates. Beneficial effects 
might be observed best among daily or near daily SLT users. This hypothesis could be investigated by 
creating similar research paradigms as for e-cigarette use, since it has been suggested that daily e-
cigarette users are more likely to have recently quit smoking and that most youthful e-cigarette users 
are infrequent users.45 
Unfortunately, in our data, daily or near daily use was too rare to conduct separate analyses. 
Only 1.3% (n=69) were daily or near daily snus users at baseline and 0.9% (n= 48) were snuff users at 
baseline. There were 0.9% (n=49) with daily or near daily snus use at both baseline and follow-up, 
and 0.25% (n=13) daily or near daily snuff maintainers. Thus, even if there were beneficial effects from 
daily SLT use, this relationship would apply only to a small minority of users in Switzerland. 
We expected differences between “illegal” snus (legal to use, but not to sell in Switzerland) and 
legal snuff. Swedish-type snus might be predominantly used in Switzerland because ice hockey is 
popular here, and snus is used to imitate certain behaviours of hockey players in North America and in 
Nordic countries.46  Snus use played some role in active sports in the present sample,46 but we could 
not find differential effects of snus and snuff use. This supports the findings of Haukkala et al.,27 that 
even among snus users active in sports, very few of them do not smoke.  
It should be noted that (legal) snuff use was far more prevalent (23.5%) than was snus use 
(9.1%). This could be due to easier availability, but could also be the result of snuff use having a long 
tradition of being a popular substance in central Europe, which includes Switzerland.35,47 Even with 
greater availability of legal snuff, it was not easier to reach goals of smoking cessation or reduction.  
Clearly, our results must be interpreted in the light of differences in the so-called smoking epidemic 
and the historical popularity of SLT in Nordic countries.28 For example snus use prevalence rates are 
much higher in Norway and Sweden compared to Switzerland,14,48 and may therefore be a culturally 
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more acceptable means for smoking cessation. Thus, snus users in Switzerland may be qualitatively 
different from snus users in countries where its use is more common. The prevalence of daily smoking 
in this sample at baseline was 19.3% (Table 1), which is much higher than prevalence rates among 
15-24 year old men in Sweden (7.6%) or Norway (5.9%).49 This may mean that in Switzerland the 
smoking epidemic has not yet reached a stage, in which SLT use to reduced or quit smoking has 
become an important alternative. 
This research contains several caveats. First, the sample consists entirely of young men, 
around age 20. Thus, the study cannot be generalized to older people, many of whom may have 
decades-long smoking histories, and who consider SLT use to be a way out of smoking.21 However, 
randomized trials on SLT use and smoking cessation reveal few long-term benefits from SLT use,23,24 
and the restriction to men is not unique to the present study. Many other studies have excluded 
women because they rarely use SLT.15,21,26,27,33  
A second caveat is that use of these products was assessed in the past 12 months at follow-
up. This was done to have a comparable recall period with other measures in C-SURF. Thus, for dual 
use initiation during follow-up, we do not know which came first, SLT use or conventional cigarette 
smoking. However, we do know (for the majority of baseline non-smoking SLT users) that the 
likelihood of becoming smokers was higher than for persistent non-users of SLT, independent of 
whether they already were users (low baseline maintainers) or initiators of SLT use.  Similarly, with the 
past 12-months assessment maintainers may be misclassified if they have already stopped their 
behaviour at the time of the follow-up interview. Also, respondents may be wrongly labelled as 
initiators when they used SLT before the 12-months baseline assessment and restarted use at follow-
up. 
Conclusion: 
SLT use did not have any beneficial effects on young men in Switzerland, but was probably 
detrimental, independent of whether the substances are sold legally (snuff) or not (snus). Whether 
sustained and frequent SLT use can produce beneficial effects in a relatively small group of people 
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deserves further study. For example, the increases in daily snus use were accompanied by strong 
reductions in the smoking prevalence in Norway or Sweden suggesting a beneficial impact of 
snus.14,48 Randomized trials have shown short-term effects of snus use for smoking cessation that 
were similar to nicotine replacement therapies50, and beneficial compared with placebo24 or 
counselling,23 but generally no long term effects. From a public health perspective in Switzerland, 
under the current regulation of SLT products and the high smoking prevalence, SLT cessation seems 
a more likely means of lessening the burden from smoking than does continued SLT use.  
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Table 1. Descriptive changes in smoking status by snus and snuff use between baseline and follow-up 
    Snus   Snuff 
Baseline 
smoking  
Follow-up 
smoking  
Persistent 
non-users  Quitters Initiators 
Low 
baseline 
maintainers 
High 
baseline 
maintainers  
Persistent 
non-users Quitters Initiators 
Low 
baseline 
maintainers 
High 
baseline 
maintainers 
Non-smokers  n 2535 42 142 38 46   2130 116 290 205 62 
 Non-smokers 87.2% 83.3% 75.4% 52.6% 84.8%  89.2% 87.1% 72.1% 74.6% 77.4% 
 Occasional 11.1% 14.3% 21.8% 36.8% 15.2%  9.3% 9.5% 24.8% 22.4% 21.0% 
 Daily 1.7% 2.4% 2.8% 10.5% 0.0%  1.5% 3.4% 3.1% 2.9% 1.6% 
Occasional 
smokers  n 1036 86 140 89 44  650 183 189 295 78 
 Non-smokers 22.2% 33.7% 8.6% 10.1% 27.3%  22.6% 32.2% 13.2% 15.3% 20.5% 
 Occasional 60.8% 57.0% 74.3% 76.4% 54.5%  59.8% 55.2% 70.4% 67.8% 66.7% 
 Daily 17.0% 9.3% 17.1% 13.5% 18.2%  17.5% 12.6% 16.4% 16.9% 12.8% 
Daily smokers n 787 54 86 60 13  594 109 120 151 26 
 Non-smokers 6.0% 11.1% 3.5% 1.7% 0.0%  6.7% 5.5% 2.5% 4.6% 3.8% 
 Occasional 9.3% 9.3% 10.5% 8.3% 23.1%  9.3% 15.6% 8.3% 7.3% 7.7% 
  Daily 84.8% 79.6% 86.0% 90.0% 76.9%   84.0% 78.9% 89.2% 88.1% 88.5% 
Note. Never users: neither use at baseline nor follow-up; Initiators: no use at baseline, but follow-up use; Quitters: mostly infrequent (and very 
rarely frequent) user at baseline, but no use at follow-up; Low baseline maintainers: infrequent use at baseline and continued use at follow-up; 
High baseline maintainers: frequent use at baseline and continued use at follow-up. 
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Table 2. Initiation of smoking at follow-up of baseline non-smokers by snus and snuff use changes between baseline and follow-up 
 
  Unadjusted models    Adjusted models* 
  b  SE Odds Ratio p-value   b SE Odds Ratio p-value  
Snus (reference: Persistent 
non-users)          
Quitters 0.37 0.42 1.44 .383  -0.07 0.43 0.94 .879 
Initiators 0.78 0.21 2.18 <.001  0.64 0.21 1.90 .003 
Low baseline maintainers 1.86 0.33 6.44 <.001  1.51 0.35 4.51 <.001 
High baseline maintainers 0.13 0.44 1.13 .778  -0.39 0.48 0.68 .418 
          
Snuff (reference: Persistent 
non-users)          
Quitters 0.24 0.29 1.27 .407  0.03 0.30 1.03 .932 
Initiators 1.17 0.15 3.21 <.001  1.13 0.15 3.09 <.001 
Low baseline maintainers 1.04 0.18 2.82 <.001  0.78 0.19 2.18 <.001 
High baseline maintainers 0.97 0.33 2.63 .003   0.62 0.34 1.85 .070 
Note. b = coefficient of association; SE = standard error of b.  Persistent non-users: neither use at baseline nor follow-up; Initiators: no use at 
baseline, but follow-up use; Quitters: mostly infrequent (and very rarely frequent) users at baseline, but no use at follow-up; Low baseline 
maintainers: infrequent use at baseline and continued use at follow-up; High baseline maintainers: frequent use at baseline and continued use at 
follow-up. *Adjustment for age, linguistic region, perceived parental financial situation, depressive symptomatology, aggressive personality, 
sensation seeking, cannabis use, binge drinking, having had problems with the police or authorities, arguments or fights, having caused property 
damage, and perceived tobacco norms.   
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Table 3. Continuation of smoking among baseline smokers by snus and snuff use changes between baseline and follow-up 
  Unadjusted models    Adjusted models* 
  b  SE Odds Ratio p-value   b SE Odds Ratio p-value  
Snus (reference: Persistent 
non-users)          
Quitters -0.62 0.21 0.54 .003  -0.57 0.22 0.57 .009 
Initiators 0.90 0.28 2.46 .001  1.03 0.28 2.79 <.001 
Low baseline maintainers 1.00 0.35 2.72 .004  1.00 0.36 2.71 .005 
High baseline maintainers -0.41 0.33 0.66 .211  -0.34 0.34 0.71 .315 
          
Snuff (reference: Persistent 
non-users)          
Quitters -0.52 0.16 0.59 .001  -0.41 0.17 0.66 .016 
Initiators 0.53 0.21 1.70 .013  0.63 0.22 1.88 .004 
Low baseline maintainers 0.28 0.17 1.32 .102  0.39 0.18 1.48 .031 
High baseline maintainers -0.07 0.28 0.93 .808   0.15 0.30 1.16 .619 
Note. b = coefficient of association; SE = standard error of b. Persistent non-users: neither use at baseline nor follow-up; Initiators: no use at 
baseline, but follow-up use; Quitters: mostly infrequent (and very rarely frequent) users at baseline, but no use at follow-up; Low baseline 
maintainers: infrequent use at baseline and continued use at follow-up; High baseline maintainers: frequent use at baseline and continued use at 
follow-up. *Adjustment for age, linguistic region, perceived parental financial situation, depressive symptomatology, aggressive personality, 
sensation seeking, cannabis use, binge drinking, having had problems with the police or authorities, arguments or fights, having caused property 
damage, perceived tobacco norms, and nicotine dependence scores.  
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Table 4. Changes in number of cigarettes smoked among continuing smokers by snus and snuff users from baseline to follow-up 
  Unadjusted models  Adjusted models* 
 b SE p-value  b SE p-value 
Snus (reference: Persistent 
non-users)        
Quitters -1.64 0.52 .002  -1.61 0.51 .002 
Initiators 0.89 0.38 .019  0.67 0.38 .078 
Low baseline maintainers -0.21 0.46 .640  -0.41 0.46 .368 
High baseline maintainers -0.11 0.78 .885  -0.33 0.77 .662 
        
Snuff (reference: Persistent 
non-users)        
Quitters -0.93 0.38 .014  -0.99 0.38 .008 
Initiators 0.55 0.35 .116  0.29 0.34 .395 
Low baseline maintainers 0.69 0.31 .024  0.42 0.31 .177 
High baseline maintainers 1.09 0.57 .057  0.58 0.58 .314 
Note. b = coefficient of association; SE = standard error of b. Persistent non-users: neither use at baseline nor follow-up; Initiators: no use at 
baseline, but follow-up use; Quitters: mostly infrequent (and very rarely frequent) users at baseline, but no use at follow-up; Low baseline 
maintainers: infrequent use at baseline and continued use at follow-up; High baseline maintainers: frequent use at baseline and continued use at 
follow-up. *Adjustment for age, linguistic region, perceived parental financial situation, depressive symptomatology, aggressive personality, 
sensation seeking, cannabis use, binge drinking, having had problems with the police or authorities, arguments or fights, having caused property 
damage, perceived tobacco norms, and nicotine dependence scores.    
 
 
 
